About the fund
Investment Advisor
Founders
Investors
Board of Directors
Business Advisory Board
Scientific Advisory Board
Management Team
Portfolio
AngioGenetics Sweden AB
CanAg Diagnostics AB
Cellectricon AB
Genizon BioSciences
Gyros AB
Independent Pharma. AB
NsGene A/S
Phasein AB
Sidec Technologies AB
Wilex
News
2008
2007
2006
2005
2004
2003
Investment Proposals
Contact
NEWS,
Karolinska Investment Fund
December 14, 2005: Cellectricon
Cellectricon launches pioneering systems for adherent cell electroporation
November 29, 2005: Cellectricon
Cellectricon Launches new Chip for Safety Pharmacology & hERG Studies
November 16, 2005: Gyros
Gyros awarded Frost & Sullivan Technology of the Year Award
November 16, 2005: EMMA™
EMMA™ World´s first self-contained, breath by breath respiratory gas analyser for proof-of-intubation and short term CO2 monitoring
November 16, 2005: PHASEIN
PHASEIN launches IRMA gas technology on the US market
October 25 2005: NsGene
Successful development of Neublastin triggers milestone payment to NsGene A/S
September 27, 2005: Wilex
Wilex appoints Norman Neville as Vice President Clinical Research & Development
August 17, 2005: Sidec Technologies
Sidec Technologies AB recruits new CSO from top-pharmaceutical R&D Award
June 21, 2005: Wilex
FierceBiotech Honors Wilex AG as One of the "Fierce 15" Biotech Companies of 2005
June 16, 2005: Cellectricon
Cellectricon signs Biodirectionz, Ltd. as distributor for their Ion Channel Drug Discovery System
May 21, 2005: Wilex
Wilex closes a EUR 30 million ($ 39 million) series C private equity round
May 19, 2005: Wilex
Wilex´s anti-cancer drug Rencarex© significantly prolongs survival in metastatic Renal Cell Cancer
May 11, 2005: Genizon BioSciences
Genizon BioSciences Acquires Assets from Global Genomics to Accelerate the Discovery of Disease-causing Mutations and Targets
May 02, 2005: NsGene
NsGene A/S moves towards clinical development with an additional DKK 30 million and introduces a new investor
Mars 16, 2005: Cellectricon
Cellectricon signs Scientifica as UK distributor for Ion Channel Drug Discovery System
February 7, 2005: Cellectricon
Cellectricon to Receive the 2004 Frost & Sullivan Market Penetration Leadership Award
January 31, 2005: Cellectricon
Cellectricon opens US unit to build on success in the cellbased assays market
Karolinska Fund - News
Phone
+46 8 50 88 44 50
Fax
+46 8 50 88 44 59
Email
marie-louise.sundin@
karolinskafund.com